132 related articles for article (PubMed ID: 3474453)
1. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
Walker MC; Parris CN; Masters JR
J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
[TBL] [Abstract][Full Text] [Related]
2. Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines.
Bedford P; Fichtinger-Schepman AM; Shellard SA; Walker MC; Masters JR; Hill BT
Cancer Res; 1988 Jun; 48(11):3019-24. PubMed ID: 3365691
[TBL] [Abstract][Full Text] [Related]
3. Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines.
Fry AM; Chresta CM; Davies SM; Walker MC; Harris AL; Hartley JA; Masters JR; Hickson ID
Cancer Res; 1991 Dec; 51(24):6592-5. PubMed ID: 1660343
[TBL] [Abstract][Full Text] [Related]
4. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
6. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
Anton-Aparicio LM; Urmeneta J; Borras M; Balaguer R; Berián JM
Actas Urol Esp; 1985; 9(6):517-22. PubMed ID: 3938597
[No Abstract] [Full Text] [Related]
7. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.
Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Hoshi A; Chen KM; Hamburger AW
Jpn J Clin Oncol; 1985 Dec; 15(4):637-44. PubMed ID: 4094096
[TBL] [Abstract][Full Text] [Related]
8. [Pretherapeutic testing of sensitivity to cytostatic drugs in primary cultures of selected urologic tumors].
Klatte D; Redmann K; Müller GW; Richter A; Gabriel D
Z Urol Nephrol; 1986 Aug; 79(8):441-7. PubMed ID: 2430377
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitivity test for human small cell lung cancer cell lines in vitro.
Takahashi H; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sano T; Nakano H; Nakagawa K; Sakurai M
Jpn J Clin Oncol; 1986 Sep; 16(3):253-60. PubMed ID: 3022034
[TBL] [Abstract][Full Text] [Related]
10. Inherent sensitivity and induced resistance to chemotherapeutic drugs and irradiation in human cancer cell lines: relationship to mutation frequencies.
Parris CN; Walker MC; Masters JR; Arlett CF
Cancer Res; 1990 Dec; 50(23):7513-8. PubMed ID: 2253200
[TBL] [Abstract][Full Text] [Related]
11. Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II).
Niell HB; Wood CA; Mickey DD; Soloway MS
Cancer Res; 1982 Mar; 42(3):807-11. PubMed ID: 7199379
[TBL] [Abstract][Full Text] [Related]
12. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L
BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines.
Walker MC; Povey S; Parrington JM; Riddle PN; Knuechel R; Masters JR
Eur J Cancer; 1990; 26(6):742-7. PubMed ID: 2144165
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of chemosensitivity tests of human urogenital tumors between a clonogenic assay and a novel dye exclusion test].
Gohji K; Okada Y; Hamami G; Kamidono S; Ishigami J; Murao S; Aogauchi R; Maeda S; Sugiyama T
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1294-300. PubMed ID: 2408580
[TBL] [Abstract][Full Text] [Related]
15. In vitro chemotherapy testing of transitional cell carcinoma.
Shrivastav S; Paulson DF
Invest Urol; 1980 Mar; 17(5):395-400. PubMed ID: 6153642
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells.
Baierlein SA; Distel L; Sieber R; Weiss C; Rödel C; Sauer R; Rödel F
Strahlenther Onkol; 2006 Aug; 182(8):467-72. PubMed ID: 16896593
[TBL] [Abstract][Full Text] [Related]
17. Sequence-dependent synergism between dichloromethotrexate and cisplatin in a human colon carcinoma cell line.
Sobrero AF; Bertino JR
Cancer Treat Rep; 1985 Mar; 69(3):279-83. PubMed ID: 4038918
[TBL] [Abstract][Full Text] [Related]
18. The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivo.
Kerr DJ; Smart HE
In Vivo; 1991; 5(4):385-8. PubMed ID: 1810425
[TBL] [Abstract][Full Text] [Related]
19. Differential drug sensitivity of human neuroblastoma cells.
Spengler BA; Ross RA; Biedler JL
Cancer Treat Rep; 1986 Aug; 70(8):959-65. PubMed ID: 3731152
[TBL] [Abstract][Full Text] [Related]
20. Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs.
Wang D; Wang Z; Tian B; Li X; Li S; Tian Y
Int J Urol; 2008 May; 15(5):435-41. PubMed ID: 18452462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
